MEDI 219-Calcitonin gene-related peptide receptor antagonists for the treatment of migraine

被引：0

作者：

Williams, Theresa M. ^{[1
]}

Burgey, Christopher S. ^{[1
]}

Paone, Daniel V. ^{[1
]}

Shaw, Anthony W. ^{[1
]}

Bell, Ian M. ^{[1
]}

Deng, James Z. ^{[1
]}

deSolms, Jane ^{[1
]}

Gallicchio, Steven N. ^{[1
]}

Nguyen, Diem N. ^{[1
]}

Potteiger, Craig M. ^{[1
]}

Stump, Craig A. ^{[1
]}

Quigley, Amy G. ^{[1
]}

Theberge, Cory R. ^{[1
]}

Wan, Bang-Lin ^{[1
]}

Zartman, C. Blair ^{[1
]}

Zhang, Xu-Fang ^{[1
]}

Kunapuli, Priya ^{[2
]}

Kane, Stefanie A. ^{[3
]}

Koblan, Ken S. ^{[3
]}

Bednar, Rodney A. ^{[3
]}

Johnston, Victor K. ^{[3
]}

Mallee, John J. ^{[3
]}

Mosser, Scott D. ^{[3
]}

Rutledge, Ruth Z. ^{[3
]}

Salvatore, Christopher ^{[3
]}

McMasters, Daniel R. ^{[4
]}

Hershey, James C. ^{[5
]}

Corcoran, Halea ^{[5
]}

Lyle, Betsy ^{[5
]}

Wong, Bradley

Roller, Shane

Miller-Stein, Cynthia M. ^{[6
]}

Rowe, Janice F. ^{[6
]}

Yu, Sean ^{[6
]}

Graham, Samuel L. ^{[1
]}

Vacca, Joseph P. ^{[1
]}

机构：

[1] Merck & Co Inc, Dept Med Chem, West Point, PA 19486 USA

[2] Merck & Co Inc, Automated Biotechnol NW1, West Point, PA 19486 USA

[3] Merck & Co Inc, Pain Res, West Point, PA 19486 USA

[4] Merck & Co Inc, Mol Syst, West Point, PA 19486 USA

[5] Merck & Co Inc, Mol Endocrinol, West Point, PA 19486 USA

[6] Merck & Co Inc, Drug Metab, West Point, PA 19486 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 234卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

219-MEDI

引用

页数：1

共 50 条

[31] Discovery and development of both intranasally and orally administered CGRP (calcitonin gene-related peptide) receptor antagonists for the treatment of migraine
Macor, John E.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[32] Calcitonin Gene-Related Peptide Antagonists as a Savior in Episodic and Chronic Migraine: A Review
Pervez, Hira
Khemani, Lavina
Khan, Mahrukh A.
Seedat, Ahmed M.
Roshan, F. N. U.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
[33] Calcitonin gene-related peptide (CGRP) antagonists: blockers of neuronal transmission in migraine
Brain, SD
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (07) : 1053 - 1054
[34] Calcitonin Gene-Related Peptide Antagonists as Treatments of Migraine and Other Primary Headaches
Peter J. Goadsby
Drugs, 2005, 65 : 2557 - 2567
[35] Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches
Goadsby, PJ
DRUGS, 2005, 65 (18) : 2557 - 2567
[36] Atogepant Calcitonin gene-related peptide (CGRP) receptor antagonist Preventive treatment of migraine
Martelletti, P.
Cipolla, F.
Capi, M.
Curto, M.
Lionetto, L.
DRUGS OF THE FUTURE, 2020, 45 (05) : 265 - 277
[37] Calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraines in adults
Ocheretyaner, Eric R.
Kofman, Maria
Quattrocchi, Elaena
DRUGS IN CONTEXT, 2022, 11
[38] Calcitonin gene-related peptide (CGRP) in migraine
Olesen, Jes
CEPHALALGIA, 2011, 31 (04) : 510 - 510
[39] Calcitonin gene-related peptide (CGRP) and migraine
Durham, PL
HEADACHE, 2006, 46 : S3 - S8
[40] Calcitonin Gene-Related Peptide Receptor Antagonists: Beyond Migraine Pain—A Possible Analgesic Strategy for Osteoarthritis?
C. M. Bullock
S. Kelly
Current Pain and Headache Reports, 2013, 17

← 1 2 3 4 5 →